Shanghai, China (July 6th, 2017) – Shanghai ChemPartner recently exhibited at the 16th International Biotech & Life Sciences Exhibition & Conferences on June 28-30 at the Tokyo Big Sight in Japan. BIOtech Japan is Asia’s leading biotechnology and pharma R&D event specialized in biotech, drug discovery, pharmaceutical development, regenerative medicine, and personalized medicine.
This comprehensive event gathered 650 exhibitors, and nearly 2000 industry insiders, including conference delegates, keynote speakers, sponsors, and guests from Asia as well as other countries around the globe. BIOtech Japan provides interactive networking opportunities involving academics, biotech companies, and pharma companies. Participants benefit from 250 wide-ranging presentations delivering new technical data, case studies, innovation, and industry brilliant insights.
ChemPartner’s biology and DMPK teams attended the exhibition to introduce ChemParter’s services to attendees. The Biology department specializes in drug discovery services for several important therapeutic areas, such as oncology including tumor immunology, immunology/inflammation, neuroscience and metabolic disorders. ChemPartner prides itself on numerous validated key discovery assays and assay panels (e.g., largest cancer lines, epigenetics, histology/pathology) for different targets. Assays and panels are routinely used and customized, and / models are performed in the AAALAC approved, state-of-the-art animal housing and breeding facility.
The Drug Metabolism Pharmacokinetic (DMPK) & Exploratory Toxicology department at ChemPartner consists of bioanalytical (regulated- and non-GLP), in vitro ADME, pharmacokinetics, and toxicology groups. The team works closely with internal medicinal chemistry, pharmacology, and biologics departments, providing support for drug discovery as well as translational medicine through expertise in formulation, 自2007年成立以来，本部门已累计为全球各地众多客户完成了数以万计化合物的ADME体外筛选试验(>80,000）以及体内药代试验 (>50,000)，用于支持早期药物的筛选。此外，DMPK部门与生物和药理药效部门及抗体开发部门密切合作，将早期制剂开发、体内体外相关性、药动/药效的模型分析、生物标记物的检测以及代谢组学等技术应用于转化医学的研究。 extrapolation, PK/PD modeling, biomarker analysis, and metabolomics.
The company looks forward to attending BIOtech 2018 to see the latest news and innovations in the industry!
FOR MORE INFORMATION
Livia Legg, MS, Chief Commercial Officer
news@chempartner.com
